USA - engelsk - NLM (National Library of Medicine)

remedyrepack inc. - insulin lispro (unii: gfx7qis1ii) (insulin lispro - unii:gfx7qis1ii) - humalog is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. humalog is contraindicated: - during episodes of hypoglycemia - in patients who are hypersensitive to humalog or to any of its excipients. risk summary the limited available data with humalog in pregnant women are insufficient to inform a drug-associated risk of adverse developmental outcomes. published studies with insulin lispro used during pregnancy have not reported an association between insulin lispro and the induction of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data) . there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations) . pregnant rats and rabbits were exposed to insulin lispro in animal reproduction studies during organogenesis. no adverse effects on embryo/fetal viability or morphology were observed in offspring of rats exposed t

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - insulin lispro - solution for injection - 100unit/1ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - insulin lispro - solution for injection - 100unit/1ml

Israel - engelsk - Ministry of Health

eli lilly israel ltd - insulin lispro; insulin lispro protamine - suspension for injection - insulin lispro 50 %; insulin lispro protamine 50 % - insulin lispro - insulin lispro - for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Singapore - engelsk - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - insulin lispro - injection - 100iu/ml - insulin lispro 100iu/ml

Singapore - engelsk - HSA (Health Sciences Authority)

eli lilly (singapore) pte ltd - insulin lispro - injection - 100 iu/ml - insulin lispro 100 iu/ml

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

deutsche homöopathie-union dhu-arzneimittel gmbh & co. kg. - origanum majorana (pot.-angaben) - urtinktur - origanum majorana (pot.-angaben) 1.0ml

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

deutsche homöopathie-union dhu-arzneimittel gmbh & co. kg. - origanum majorana (pot.-angaben) - tablette - origanum majorana (pot.-angaben) 0.25g

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

deutsche homöopathie-union dhu-arzneimittel gmbh & co. kg. - origanum majorana (pot.-angaben) - flüssige verdünnung zur injektion - origanum majorana (pot.-angaben) 1.0ml

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

wala-heilmittel gmbh (3092764) - thuja occidentalis e summitatibus ferm (pot.-angaben); lilium lancifolium (pot.-angaben); kreosotum (pot.-angaben); argentum colloidale (pot.-angaben); origanum majorana (pot.-angaben); echinacea pallida e planta tota ferm (pot.-angaben); calendula officinalis ferm (pot.-angaben); salbeiöl; thymianöl vom thymol-typ; rosmarinöl; eucalyptusöl ((mit angaben zur herkunft)); milchsäure - gel - teil 1 - gel; thuja occidentalis e summitatibus ferm (pot.-angaben) (09386) 0,1 gramm; lilium lancifolium (pot.-angaben) (02735) 0,1 gramm; kreosotum (pot.-angaben) (06125) 0,1 gramm; argentum colloidale (pot.-angaben) (05245) 0,1 gramm; origanum majorana (pot.-angaben) (14999) 0,1 gramm; echinacea pallida e planta tota ferm (pot.-angaben) (09388) 0,1 gramm; calendula officinalis ferm (pot.-angaben) (10249) 0,1 gramm; salbeiöl (02829) 0,01 gramm; thymianöl vom thymol-typ (02697) 0,01 gramm; rosmarinöl (01258) 0,01 gramm; eucalyptusöl ((mit angaben zur herkunft)) (00123) 0,02 gramm; milchsäure (00203) 0,03 gramm